Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Iot symbols : Pbyi save search
Puma Biotechnology Announces $10 Million Private Placement
Published: 2022-03-10 (Crawled : 01:00) - biospace.com/
PBYI | $4.95 -0.8% 120K
|
Health Technology
|
| O: -1.68%
H: 0.0%
C: 0.0%
ces technology biotech iot
Puma Biotechnology to Participate in Breast Cancer Panel at Cowen’s Annual Health Care Conference
Published: 2022-03-07 (Crawled : 19:00) - biospace.com/
PBYI | $4.95 -0.8% 120K
|
Health Technology
|
| O: -1.59%
H: 0.0%
C: 0.0%
health technology conference cancer biotech iot breast cancer
Puma Biotechnology to Host Conference Call to Discuss Fourth Quarter and Full Year 2021 Financial Results
Published: 2022-02-16 (Crawled : 22:00) - biospace.com/
PBYI | $4.95 -0.8% 120K
|
Health Technology
|
| O: 0.0%
H: 1.52%
C: 0.0%
financial results technology conference results biotech iot
Puma Biotechnology’s NERLYNX® Included in Two Important NCCN Clinical Practice Guideline Updates for the Treatment of Breast Cancer
Published: 2022-01-12 (Crawled : 23:00) - biospace.com/
PBYI | $4.95 -0.8% 120K
|
Health Technology
|
| O: 0.36%
H: 0.73%
C: -4.73%
nerlynx treatment technology cancer biotech iot breast cancer
Puma Biotechnology Presents Updates from the SUMMIT Trial at the 2021 SABCS Annual Meeting
Published: 2021-12-10 (Crawled : 19:00) - biospace.com/
PBYI | $4.95 -0.8% 120K
|
Health Technology
|
| O: 3.19%
H: 0.0%
C: 0.0%
sabcs technology trial biotech iot
Puma Biotechnology Reports Third Quarter 2021 Financial Results
Published: 2021-11-04 (Crawled : 22:00) - biospace.com/
PBYI | $4.95 -0.8% 120K
|
Health Technology
|
| O: -0.46%
H: 3.21%
C: -2.44%
financial results results biotech technology iot
Puma Biotechnology Reports Second Quarter 2021 Financial Results
Published: 2021-08-05 (Crawled : 22:00) - biospace.com/
PBYI | $4.95 -0.8% 120K
|
Health Technology
|
| O: 1.46%
H: 1.44%
C: 0.58%
financial results results biotech technology iot
Puma Biotechnology Secures $125 Million Note Purchase by Athyrium Capital
Published: 2021-07-26 (Crawled : 14:00) - biospace.com/
PBYI | $4.95 -0.8% 120K
|
Health Technology
|
| O: 0.13%
H: 1.48%
C: 0.0%
biotech technology iot
FDA Approves Dose Escalation Label Update for Puma Biotechnology’s NERLYNX® (neratinib) in HER2-Positive Early Stage and Metastatic Breast Cancer
Published: 2021-07-01 (Crawled : 13:00) - biospace.com/
PBYI | $4.95 -0.8% 120K
|
Health Technology
|
| O: 0.11%
H: 3.16%
C: 2.18%
fda positive cancer biotech technology iot breast cancer fda approval her2+ her2- her2 metastatic breast cancer
Puma Biotechnology Presents Data from the EGFR Exon 18-mutant NSCLC Cohort of the Phase II SUMMIT Trial at the 2021 ASCO Annual Meeting
Published: 2021-06-04 (Crawled : 17:00) - biospace.com/
PBYI | $4.95 -0.8% 120K
|
Health Technology
|
| O: 0.56%
H: 5.59%
C: 3.87%
biotech technology iot trial
Puma Biotechnology Presents Data Comparing Findings from the Phase II CONTROL Trial with the Neratinib Arm of the Phase III ExteNET Trial at the ASCO 2021 Annual Meeting
Published: 2021-06-04 (Crawled : 17:00) - biospace.com/
PBYI | $4.95 -0.8% 120K
|
Health Technology
|
| O: 0.56%
H: 5.59%
C: 3.87%
biotech technology iot trial
Gainers vs Losers
| 77% | 23% |
Top 10 Gainers
AGBA | News | $1.22 205.0% 86M
|
Finance
EGOX | $0.054 50.0% 290M
|
CHRO | $1.66 35.51% 70K
|
n/a
INDO | $5.43 33.09% 10M
|
Energy Minerals
NVFY | $2.71 28.44% 31M
|
Consumer Durables
ZCMD | $1.86 28.28% 29M
|
Commercial Services
RWOD | $10.08 26.05% 5.6M
|
n/a
HUSA 4 | $2.07 23.95% 2.1M
|
Energy Minerals
TPET | $0.4001 22.02% 35M
|
n/a
SRFM 4 | $0.6 21.29% 850K
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.